In February 2026, the American Heart Association (AHA) and the American College of Cardiology (ACC) published a new guideline on the assessment and treatment of acute pulmonary embolism in cooperation with other US professional societies. An important innovation is the introduction of clinical categories (A-E), which are intended to improve the severity classification, prognosis assessment and evidence-based therapeutic decision-making in acute pulmonary embolism.
Autoren
- Mirjam Peter, M.Sc.
Publikation
- HAUSARZT PRAXIS
Related Topics
You May Also Like
- Acute pulmonary embolism: new AHA/ACC guideline
Practical recommendations for risk-stratified triage
- Why lipoprotein(a) is the biggest therapeutic vacuum in cardiology
Lp(a): The underestimated risk factor before the turning point
- Modern system therapeutics for hidradenitis suppurativa
Immunological dysregulation in the sights of several biologics and “small molecules”
- Perimenopausal depression, PMDS and tokophobia
Psychosomatics and mental health in gynecology
- Proteins in wound healing
Do special amino acids lead to success?
- Plastic surgery and reconstructive microsurgery for DFS
Functional limb preservation between infection control, vascular medicine and resurfacing
- Polycystic ovary syndrome 2025/2026
New pathophysiology, updated diagnostics and the age of incretin mimetics
- Heart failure and type 2 diabetes